VertiFlex gained a PMA approval for its Superion Interspinous Spacer System to treat spinal stenosis. The device is designed to be the least invasive, motion-preserving spinal spacer device. The ...
Boston Scientific has moved to acquire Vertiflex, maker of a minimally invasive vertebrae spacer for treating lumbar stenosis, or the painful narrowing of the open spaces within the lower spinal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Orthopaedic and Rehabilitation Devices Panel of the ...
(May 26, 2015) VertiFlex, Inc., announced that it has been granted pre-market approval by the FDA for its minimally invasive treatment of lumbar spinal stenosis, the Superion Interspinous Spacer ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced the completion of enrollment in ...
Spacer to countries outside the USA. The Superion implant is placed percutaneously between the spinous processes without the need to cut paraspinal muscles. It is primarily designed to offer relief ...
Technology: VertiFlex develops minimally invasive products for the treatment of lumbar spinal stenosis. Its Superion Interspinous Spacer system was approved by the FDA last year and is "designed to ...
VertiFlex earned FDA PMA Approval Order for the Superion Interspinous Spacer System. 1. Earlier this year, the FDA Advisory Panel voted that Superion demonstrated safety and effectiveness and a ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — An interspinous device designed to treat patients with lumbar spinal stenosis implanted using a ...
SAN CLEMENTE, Calif.– VertiFlex®, Inc., a leading innovator of percutaneous and motion preserving spinal surgery technologies, today announced completion of a $14M equity placement, with provision for ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of percutaneous and motion preserving spinal surgery technologies, today announced completion of a $14M equity placement, ...